tert-Butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride

Catalog No. :
ACYHRE024
CAS No. :
2173992-06-6
Molecular Formula :
C11H23ClN2O2
Molecular Weight :
250.77

IUPAC Name:tert-butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride

tert-Butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$123.00Login to see priceInquiryInquiry
250mg95%$153.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride
IUPAC Nametert-butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride
MDL No.MFCD30726544
Molecular FormulaC11H23ClN2O2
Molecular Weight250.77
SMILESO=C(OC(C)(C)C)NCC1(C)CNCC1.[H]Cl
InChI KeyBEQOVTDTBMZGKE-UHFFFAOYSA-N
Synonymtert-butyl N-[(3-methylpyrrolidin-3-yl)methyl]carbamate hydrochloride;N-Boc-1-(3-methyl-3-pyrrolidinyl)methanamine Hydrochloride;tert-butyl N-[(3-methylpyrrolidin-3-yl)methyl]carbamate hydrochloride - [B85031];tert-butyl ((3-methylpyrrolidin-3-yl)methyl)carbamate hydrochloride
CAS No.2173992-06-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYHRE024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJNFH691 route compound structure diagram
    ACJNFH691872716-54-6 In Stock
  2. Then
  3. ACYHRE024 route product structure diagram
    ACYHRE0242173992-06-6
Inquiry

2. ACYHRE024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYHRE024 route product structure diagram
    ACYHRE0242173992-06-6
Inquiry

Comments (0)